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Effect of Polycaprolactone Scaffold Permeability
on Bone Regeneration In Vivo
Anna G. Mitsak, M.S.,1 Jessica M. Kemppainen, Ph.D.,1 Matthew T. Harris, M.S.,1 and Scott J. Hollister, Ph.D.1–3
Successful bone tissue engineering depends on the scaffold’s ability to allow nutrient diffusion to and waste
removal from the regeneration site, as well as provide an appropriate mechanical environment. Since bone is
highly vascularized, scaffolds that provide greater mass transport may support increased bone regeneration.
Permeability encompasses the salient features of three-dimensional porous scaffold architecture effects on scaffold
mass transport. We hypothesized that higher permeability scaffolds will enhance bone regeneration for a given cell
seeding density. We manufactured poly-e-caprolactone scaffolds, designed to have the same internal pore design
and either a low permeability (0.688· 10- 7m4/N-s) or a high permeability (3.991· 10- 7m4/N-s), respectively.
Scaffolds were seeded with bone morphogenic protein-7-transduced human gingival fibroblasts and implanted
subcutaneously in immune-compromised mice for 4 and 8 weeks. Micro-CT evaluation showed better bone
penetration into high permeability scaffolds, with blood vessel infiltration visible at 4 weeks. Compression
testing showed that scaffold design had more influence on elastic modulus than time point did and that bone
tissue infiltration increased the mechanical properties of the high permeability scaffolds at 8 weeks. These results
suggest that for polycaprolactone, a more permeable scaffold with regular architecture is best for in vivo bone
regeneration. This finding is an important step toward the end goal of optimizing a scaffold for bone tissue
engineering.
Introduction
Biomaterial scaffolds delivering osteogenic factorsare a potential alternative to traditional repair techniques
for challenging clinical bone defects resulting from trauma,
tumor resection, and developmental anomalies. Defining the
optimal scaffold for these purposes requires determination of
key parameters that have the greatest influence on bone re-
generation. For defects of clinically relevant size and shape,
the scaffold should allow sufficient nutrient diffusion and
waste removal while simultaneously providing adequate
load bearing capabilities. Generally speaking, there is a
trade-off between these two requirements, as scaffold archi-
tectures designed to maximize nutrient diffusion typically
result in decreased scaffold mechanical strength. Optimiza-
tion of scaffold design to satisfy both of these constraints
remains a challenge. Therefore, it is important to understand
the impact that each of these putative design requirements
have on bone regeneration.
Porosity, pore size, and permeability are interrelated ar-
chitectural properties that have been shown to influence both
diffusion and scaffold mechanical properties.1,2 Unlike po-
rosity, pore size, and a number of other structural parame-
ters that have been studied, permeability defines the physical
property of mass transport, which inherently describes the
effects that these structural design properties have on fluid
transport into and out of a construct. The effects that scaffold
permeability has on bone tissue regeneration have not been
studied in depth using rigorously controlled porous archi-
tectures with reproducibly designed effective permeability.
In this work, scaffolds are designed such that permeability
changes, whereas pore shape, pore size, and pore inter-
connectivity are held constant between groups to specifically
compare the effects of increasing permeability on bone
growth. Image-based design combined with solid free form
fabrication (SFF) enables the creation of scaffolds that have
precise permeability characteristics resulting from rigorously
controlled three-dimensional (3D) architecture. By using
these techniques, the effects that permeability has on the
growth of bone tissue into a scaffold can be investigated,
providing important considerations for developing opti-
mized constructs.
In recent literature, the range of variables examined for
their effect on bone growth extends beyond scaffold design
to include cell type, growth factors, and scaffold material.
Common cell types studied for bone regeneration include
fibroblasts, osteoblasts, and stem cells, often combined with
one or more growth factors such as insulin-like growth
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factor, transforming growth factor beta, or bone morpho-
genic proteins (BMP). These cells and growth factors are
housed within scaffolds made of a variety of materials.
Polypropylene fumarate,3,4 poly-e-caprolactone (PCL),5–7
polylactic acid,8,9 and poly(lactic-co-glycolic) acid10,11 are
bioresorbable polymers that have all been investigated, alone
or in combination, for bone applications, as have osteo-
conductive materials such as tricalcium phosphate,8 hy-
droxyl apatite,12 and calcium phosphate.13,14
This work employs the use of PCL scaffolds seeded with
BMP-7-transduced human gingival fibroblasts to study the
effects that permeability has on bone tissue regeneration.
PCL has been used extensively for tissue engineering appli-
cations.5–7,15,16 The degradation profile and mechanical
properties of this polymer support its use for bone tissue
engineering. In terms of manufacturability, the polymer is
favorable both for studying scaffold architecture effects on
tissue regeneration and for subsequent clinical tissue engi-
neering applications, as PCL scaffolds can be created using
many SFF techniques. These include selective laser sinter-
ing,6 fused deposition modeling,15 photopolymerization of
PCL macromer,16 and 3D printing.7 Specifically for the pur-
poses of this study, PCL is compatible with the image-based
design and 3D printing-direct casting techniques we have
used to fabricate consistent, reproducible scaffolds with de-
signed architectures. BMP-7-transduced fibroblasts were
utilized as a cell source known to reproducibly generate bone
in ectopic sites.7,17 Various studies have investigated scaffold
architectures that may or may not affect bone growth, with
many hypothesizing that results are dependent on the fluid
flow and nutrient/waste diffusion properties imposed by the
design parameters utilized.1,2,16 Roosa et al.7 determined that
different pore sizes (350, 500, and 800 mm) had little effect on
in vivo bone growth using PCL scaffolds. Others have con-
cluded that increased scaffold porosity is important for cell
delivery18 and sufficient diffusion of nutrients and waste into
and out of the scaffold. While studies may support or refute
the requirement of specific pore sizes and shapes, strut/fiber
diameters, interconnectivity, or porosities individually for
optimal bone growth, it is important to acknowledge that
these design parameters (1) are related to and contingent on
one another, and (2) may have a profound effect on the
mechanical properties of scaffolds. This work primarily ad-
dresses the first challenge by proposing a more definitive
way to examine impacts that scaffold architectures may have
on tissue growth. This is done by studying the effects of
scaffold permeability, a design parameter that, in terms of
fluid flow, incorporates all of these design variables.
This work also addresses the second concern of main-
taining sufficient mechanical properties to support develop-
ing tissue while optimizing scaffold architecture for
enhanced bone regeneration. By inference, if permeability is
shown to affect the amount of bone generated on PCL scaf-
folds, structural parameters such as pore size and shape,
interconnectivity, strut size and shape, and porosity can be
manipulated to meet biomechanical requirements, whereas
permeability requisites are also maintained within desired
ranges. Alternatively, if permeability is shown to have no
effect on bone regeneration, these structural parameters can
be optimized strictly for mechanical or other desired prop-
erties. Further, the work determines the mechanical proper-
ties of the scaffold architectures used and compares their
modulus and strength to that of native bone as a proof of
concept for using PCL to fabricate scaffolds for bone tissue
applications.
This study specifically addresses the importance of scaf-
fold permeability as a design parameter and the need for
balancing pore geometry with mechanical properties to cre-
ate scaffolds that allow for bone regeneration and support
load, and can be easily manufactured. By utilizing two
scaffold designs that held pore shape, pore size, and pore
interconnectivity constant yet resulted in differing perme-
ability, the effect that the latter parameter has on bone re-
generation was evaluated in terms of (1) volume, mineral
density, and mineral content of bone within the entire scaf-
fold, assessed by micro-computed tomography (mCT) and
histology, (2) penetration of bone through the interior of the
scaffold, assessed by mCT analysis with concentric regions of
interest [ROI], and (3) compressive modulus and strength of
resultant bone–polymer constructs, assessed by unconfined
compression testing for 4 and 8 weeks in a previously
characterized immune-compromised mouse model.7,17,19
Materials and Methods
Scaffold fabrication
Low and high permeability scaffolds were previously
designed to have a permeability of 0.688 or 3.991 ( · 10 - 7m4/
N-s), respectively.20 The low and high permeability designs
have porosities of 53.46% and 70%, and surface areas of
317.69 and 260.52 mm2, respectively. The designs and asso-
ciated properties are displayed in Table 1. Inverse wax molds
were built on a Solidscape Model Maker II machine (So-
lidscape, Merrimack, NH) and subsequently melt cast into
PCL powder (43–50 kDa; Polysciences, Warrington, PA) at
115C. The cast scaffolds were cooled and hardened over-
night in a Teflon mold, placed in 100% ethanol to dissolve
the wax mold, trimmed, and cleaned with wire. Before cell
seeding, the scaffolds were sterilized by placing them in 70%
ethanol for 24 h, followed by sterile water for 24 h and se-
rum-free medium overnight.
Cell culture and subcutaneous implantation procedure
Human gingival fibroblasts (ScienCell Research Labora-
tories, Carlsbad, CA) were cultured in Dulbecco’s modified
Table 1. Scaffold Design Parameters
Permeability
( · 10 - 7 m4/N-s)
Porosity
(%)
Surface
area (mm2)
Pore
shape
Pore
size (mm)
Pore
interconnectivity (%)
Low permeability 0.688 53.46 317.69 Sphere 1.0 100
High permeability 3.991 70 260.52 Sphere 1.0 100
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Eagle’s medium, supplemented with 10% fetal calf serum
and 5% penicillin/streptomycin (all reagents from Gibco,
Carlsbad, CA). Four-week and 8-week studies were carried
out separately. For each study, cells were cultured until a
sufficient number of cells were reached. The day before im-
plantation, the cells were transduced with Ad-BMP-7 (Vector
Core, University of Michigan, Ann Arbor, MI) at a concen-
tration of 500 plaque forming units per cell. On the day of
implantation, 0.75 · 106 cells were seeded into each scaffold
(6.35 mm diameter, 3 mm height) using a 1:20 thrombin:fi-
brinogen gel for cell encapsulation. Previous studies have
confirmed even seeding of cells throughout the scaffolds
using this technique. Seeded scaffolds (n= 18 per low and
high permeability design, for each time point) were kept on
ice before subcutaneous implantation in the backs of NIHS-
bg-nu-xid mice (Harlan Laboratories, Indianapolis, IN).
Scaffolds infiltrated with a 1:20 thrombin/fibrinogen gel
alone (no cells) were used as controls. After 4 or 8 weeks,
mice were euthanized and scaffolds were removed, and then
placed in Z-Fix overnight, in water for 2 h and stored in 70%
ethanol. Fourteen specimens were excluded from analysis (2
low permeability/4 weeks, 7 low permeability/8 weeks, and
5 low permeability/8 weeks) due to the death of three ani-
mals and difficulties encountered in scaffold processing. This
study was conducted in accordance with the regulations set
forth by the University Committee on Use and Care of An-
imals at the University of Michigan.
lCT analysis
Explanted, fixed scaffolds were scanned in water with a
high-resolution mCT scanner (GE Medical Systems, Toronto,
Canada) at 75 kV and 75 mA. Bone volume (BV) was ana-
lyzed using GEMS Microview software (GE Medical Sys-
tems) to obtain BV, tissue mineral density (TMD), and tissue
mineral content (TMC) data, using a bone threshold value of
1100. TMD measures the degree of mineralization of tissue
that has been designated bone by the mCT threshold analysis
value (1100) within a given volume, and has units of mass of
hydroxyapatite per volume (mg HyAp/mL). TMC quantifies
the amount of mineralized tissue in the given ROI and has
units of mass of hydroxyapatite (mg HyAp). A cubic ROI
exceeding scaffold boundaries was used for ‘‘total bone
volume’’ values (includes bone grown inside and outside
scaffold boundaries). To assess the bone grown within the
entire scaffold, a cylindrical ROI with fixed x and y-dimen-
sions of 6.3455 mm and an average z-dimension of
2.5786 – 0.3963 was used. The total volume of bone generated
within scaffold boundaries (‘‘scaffold bone volume’’), the
percentage of available pore space occupied by bone (‘‘bone
in-growth’’), TMD, and TMC were calculated. Pore volume
fractions of 0.574 and 0.738 (for the low and high perme-
ability designs, respectively) were multiplied by bounding
scaffold dimensions to calculate available pore volume.
To assess the amount and quality of bone grown at vari-
ous radial distances into the scaffold, mCT analysis was
performed on each specimen using four concentric, hollow,
cylindrical ROIs, with the same ‘‘z’’ dimensions as the entire
scaffold ROIs and having outer diameters of 6.35, 5.06, 3.81,
and 2.54 mm. Each of the four ROIs had inner diameters of
5.06, 3.81, 2.54, and 0.00 mm, respectively. BV, bone in-
growth, TMD, and TMC were calculated for each ROI.
Unconfined compression testing
Explanted, fixed experimental and control scaffolds were
mechanically tested in unconfined compression using an
MTS Alliance RT30 electromechanical test frame (MTS Sys-
tems Corp., Minneapolis, MN). Specimens were compressed
to 40% strain between two fixed steel platens at a rate of
1.0 mm/min after a 0.5 lbf preload was applied. Data were
collected and analyzed using TestWorks4 software (MTS
Systems Corp.). Compressive modulus was defined as the
slope of the tangent line to the stress–strain curve at 12.5%
strain. Compressive yield strength was calculated as the load
carried at the 0.2% offset point divided by the original scaf-
fold cross-sectional area.
Histology
At each time point, two fixed scaffolds from each group
were sectioned and stained with hematoxylin and eosin to
observe tissue morphology. Sections were viewed under a
light microscope and images were obtained at 50 · , 100· ,
200· , and 400 · magnification
Statistics
Multiple linear regression, performed using SPSS software
(SPSS for Windows, Rel 14.0. 2005; SPSS, Inc., Chicago, IL),
was used to determine which factors (scaffold design or
time) had a significant effect on a given response variable.
Results
Micro-CT
Entire scaffold analysis. mCT analysis demonstrated that
total BV (scaffold BV plus bone surrounding the scaffold) did
not differ between the low and high permeability scaffold
designs at either time point. However, scaffold BV did differ
between designs (see Fig. 1a). Scaffold BV was significantly
greater for the high permeability design ( p£ 0.05) as com-
pared to the low permeability design at 4 weeks and was
also greater for the high permeability design at 8 weeks,
although this difference was not significant ( p= 0.11). Both
designs demonstrated a statistically significant increase in
scaffold BV at 8 weeks as compared to 4 weeks ( p£ 0.01).
Bone in-growth (Fig. 1b) significantly increased with time
( p £ 0.05) for both designs. Also, the high permeability de-
sign showed greater bone in-growth as compared to the low
permeability design at 4 weeks ( p£ 0.05). At 8 weeks, the
high permeability scaffolds again averaged a higher bone in-
growth than low permeability scaffolds, but this difference
was not significant ( p= 0.25). mCT slices through the middle
of a high and a low permeability scaffold after 8 weeks
in vivo (Fig. 2b, d) show that there appears to be more
mineralized tissue in the center of the high permeability
scaffolds, compared to the low permeability scaffolds. The
concentric cylinder analysis further demonstrated this phe-
nomenon (see below).
TMC values within the scaffold space for 4 and 8 weeks
are displayed in Figure 3a. Time had a greater influence on
TMC than scaffold design did, with significant increases in
TMC from 4 to 8 weeks for both scaffold designs ( p£ 0.05).
TMC was also greater for high permeability scaffolds com-
pared to low permeability scaffolds at 4 weeks ( p£ 0.05).
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Average TMD values for bone grown on each design at both
4 and 8 weeks (range = 360–600 mg/mL) fell within the ran-
ges of normal human trabecular and cortical bone21 and are
displayed in Figure 3b. Time in vivo had a greater influence
on TMD values than scaffold design did. No significant
differences in TMD were seen between scaffold design at
either time point, but TMD increased significantly from 4 to 8
weeks for both scaffold designs ( p£ 0.05).
Concentric cylinder analysis. The diameters of the cy-
lindrical ROIs were decreased by 1.29 mm each time to create
a set of four, concentric ROIs, as shown in Figure 4. For each
of these regions, the high permeability scaffolds at 8 weeks
contained more BV than their low permeability counterparts,
with significant differences ( p£ 0.01) for ROI 2, ROI 3, and
ROI 4 (ROI 1 did not show significance at a 0.05 level, al-
though the p-value was still relatively low, at p = 0.1), as
shown in Figure 5a. This shows that bone penetrated into the
center of the scaffold and was not confined to the edges of
the scaffold. For bone in-growth, the most interesting com-
parisons were those between ROIs for each scaffold design
group, as shown in Figure 5b. For both scaffold designs at 4
weeks and for the low permeability design at 8 weeks, in-
growth significantly decreased going from the entire scaffold
FIG. 2. Micro-CT image slices
from the center of representative
low and high permeability scaf-
folds. (a) Low permeability scaffold
at 4 weeks, (b) low permeability
scaffold at 8 weeks, (c) high per-
meability scaffold at 4 weeks, and
(d) high permeability scaffold at
8 weeks. Color images available
online at www.liebertonline.com/
tea
FIG. 1. (a) Bone volume
(BV) inside the scaffold ROI at
4 and 8 weeks. (b) Bone in-
growth for the entire scaffold
ROI at 4 and 8 weeks.
*p£ 0.05. **p£ 0.01. ROI,
region of interest. Color ima-
ges available online at
www.liebertonline.com/tea
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ROI to smaller ROIs. This would suggest that for these
groups, in-growth is not maintained throughout the scaffold.
However, for the high permeability scaffolds at 8 weeks, this
decrease is not observed, demonstrating that in-growth of
bone is seen throughout the entire scaffold progressing
through to the center of the scaffold.
Compression testing
Tangent modulus at 12.5% strain and compressive yield
strength at the 0.2% offset yield point are shown in Figure 6
for both scaffold designs and both time points. Modulus and
compressive yield strength values of low permeability scaf-
folds were significantly higher than those for high perme-
ability scaffolds at 0, 4, and 8 weeks ( p £ 0.01). Time in vivo
did not significantly affect tangent modulus values of scaf-
fold–bone constructs for the low permeability design. How-
ever, for the high permeability design, there is a significant
increase ( p £ 0.01) in modulus at 8 weeks. Similarly, com-
pressive yield strength (Fig. 6b) increases significantly
( p £ 0.05) from 0 to 4 and from 4 to 8 weeks for the high
permeability design. Average yield strength of low perme-
ability constructs also increased between zero and 4 weeks
( p £ 0.01), but a decrease was seen between 4 and 8 weeks
( p £ 0.01).
Histology
Histological analysis confirmed bone growth (reported
quantitatively through mCT assessment) in and around
scaffold pores. Figure 7 shows representative histological
sections from an 8-week, high permeability scaffold at 50 ·
and 400 · (panels a and b, respectively), and an 8-week, low
permeability scaffold at 50· and 400 · (panels c and d, re-
spectively). In the low magnification images, the dark pink
staining representing bone is indicated by the arrows and is
FIG. 3. (a) Tissue mineral
content (TMC) and (b) tissue
mineral density (TMD) at 4
and 8 weeks. *p£ 0.05. Color
images available online at
www.liebertonline.com/tea
FIG. 4. Micro-CT slice im-
ages showing top-down
views of the cylindrical ROIs
used for the concentric BV
analysis. (a–d) show the four
concentric ROIs, each with a
progressively smaller outer
diameter, and (e) shows all
four ROIs overlaid on one
another. Color images avail-
able online at www
.liebertonline.com/tea
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visible in the pore spaces of the representative high perme-
ability scaffold (a). For the low permeability scaffold (c), this
dark pink staining is mainly seen toward the outer edges of
the construct. Marrow space is indicated in the images by the
letter ‘‘M,’’ osteocytes in lacunae are circled, and blood vessel
infiltration is indicated by ‘‘BV.’’ All scaffolds displayed a
thin layer of bone around the outside of the scaffold. Com-
pared to lower permeability scaffolds, the higher perme-
ability scaffolds showed more evidence of bone spicules
growing within the pore space, as shown by greater areas of
dark pink staining.
Discussion
The ultimate goal of utilizing biomaterial scaffolds for
bone tissue engineering applications is to develop constructs
that support or even enhance bone regeneration while hav-
ing the capability to bear appropriate amounts of load. To
achieve this, the construct must allow sufficient nutrient in-
filtration to sustain cell recruitment, differentiation, and tis-
sue remodeling after implantation. The scaffold must also
provide adequate strength to support surrounding tissue
and new tissue during development. It is well accepted that
such requirements can be achieved using porous scaffolds as
the basis of the tissue-engineered construct; however, there is
no data that identify how permeable these constructs must
be to support or enhance bone regeneration. In this work,
permeability effects on bone growth in vivo were determined
with scaffolds of low and high (5.8 · low) permeability.
The utilization of SFF techniques allows more rigorous
control of scaffold architecture compared to previous studies
where salt leached,18 gas foamed, or emulsion constructs
demonstrated that higher porosity enhances osteogen-
esis.22,23 For this work, pore size (1 mm), pore shape
(spherical), and pore interconnectivity (100%) were kept
constant between the two permeability designs (high and
low). Variation in permeability was created through chang-
ing the amount of overlap between spherical pores, which
resulted in differences in porosity, throat size, and surface
area, as these design features are interrelated. Higher po-
rosity often results in higher scaffold surface area, which
enhances ion exchange and bone-inducing factor adsorption,
provided that the scaffold material is hydrophilic and cell-
friendly. However, increased porosity does not necessarily
result in increased surface area, as demonstrated by the
higher porosity scaffolds utilized in this work that had lower
FIG. 5. Concentric cylinder BV analysis. (a) BV and (b) bone in-growth for high and low permeability scaffolds and 4 and 8
weeks, for four hollow, cylindrical ROIs. **p£ 0.01. Color images available online at www.liebertonline.com/tea
FIG. 6. (a) Tangent modulus
at 12.5% strain, 4 and 8 weeks.
(b) Compressive yield
strength at 0.2% offset.
*p£ 0.05. **p£ 0.01. Color
images available online at
www.liebertonline.com/tea
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surface area than the lower porosity scaffolds. It is possible
that this decreased surface area may have been advanta-
geous for cell infiltration due to the hydrophobicity of the
PCL scaffold material used here.
Numerous studies (described below) demonstrate that
pore size, interconnectivity, and porosity affect bone tissue
regeneration, and these three design features appear to be
the most important structural variables in an initial scaffold
screening algorithm developed by Cleyenbreugel et al.22 for
bone tissue engineering applications. It is difficult to keep all
three of these variables constant and create two scaffolds of
differing permeability that can be built successfully. The
scaffolds used here were successfully designed to hold two
out of the three variables constant, pore size and inter-
connectivity, to elucidate changes in bone growth caused
only by variations in permeability. Pore and throat size,
mutually and collectively, influence the diffusion of materi-
als through a scaffold and thus affect nutrient delivery and
cell infiltration. Gross pore size alone influences the mode of
bone tissue development. A minimum pore size of 300mm is
required for microvessel formation, which greatly improves
the flow of nutrients to the interior of the scaffold.24 Larger
pores ( > 300 mm) lead to direct osteogenesis as opposed to
endochondral ossification. Jones et al.2 argue that accessible
pore size is the most relevant design variable to consider for
bone infiltration into a scaffold, and that it must be at least
100 mm. Scaffolds used in this work were designed with a
pore size of 1000 mm, allowing ample space for cells and
vessels to infiltrate and bone tissue to develop. The larger
pore size also enabled manufacturing of regular pore archi-
tecture by SFF. However, large pore size does not guarantee
successful tissue regeneration since the overall pore archi-
tecture affects accessibility of internal scaffold pores. Throat
size and accessible pore size, together, enable initial cell
penetration and nutrient and waste diffusion. Otsuki et al.25
found that 52 mm is the minimum throat size allowable for
adequate bone and tissue in-growth in vivo. mCT quantifi-
cation and histology in this work illustrate the effectiveness
of larger throat sizes (390 and 610 mm for the low and high
permeability designs, respectively), as bone penetrated into
the center of both scaffold design groups.
There have been few studies that directly examined con-
struct permeability and its effect on bone regeneration. Hui
et al.26 proposed that below a threshold fluid conductance,
vascularization into cancellous autograft constructs was poor
and bone regeneration minimal. However, when interpreting
fluid conductance (permeability times construct area divided
by construct length) data, it is unclear whether the intrinsic
permeability is limiting bone in-growth or whether the size
of the construct requires a longer time for creeping substi-
tution of bone. Jones et al.2 proposed that the fluid conduc-
tance data of Hui et al.26 along with their own data suggest a
minimum intrinsic permeability of 3· 10 - 8 m4/Ns to allow
bone in-growth independent of the time period. The per-
meabilities of scaffolds used in this study were 6.9 and
39.9 · 10- 8 m4/Ns, well above the threshold permeability
proposed by Jones et al.2 To further examine how the scaffold
designs used here affected the growth of bone into interior
void spaces, percent increases in scaffold BV from 4 to 8
weeks were calculated for each scaffold design group. The
high permeability scaffolds showed an average increase in
scaffold BV of 106%, whereas low permeability scaffolds had
only a 62.3% increase. Granted, these average values do not
account for variability, but they suggest that, in this model,
increasing permeability may increase the rate and penetra-
tion of bone in-growth into the interior void spaces of scaf-
folds. Advantageous to tissue engineering applications that
employ such findings, the variable of permeability is not
confined by a particular pore size or shape to achieve desired
properties, enabling optimization of mechanical properties
FIG. 7. Representative histologi-
cal sections of high permeability
(a, b) and low permeability (c, d)
scaffolds at 8 weeks. (b) and (d)
are higher magnification images
of rectangular insets indicated in
(a) and (c). The scaffold is indi-
cated by ‘‘S’’ and bone growth in
and around the scaffold is indi-
cated by the dark pink staining
and arrows. Osteocytes in lacunae
are seen in both high and low
permeability scaffolds (indicated
by dashed circles) as is marrow
space (‘‘M’’). Blood vessels are
also seen in the high permeability
scaffold (BV). Color images avail-
able online at www.liebertonline
.com/tea
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or other tissue regeneration constraints in light of perme-
ability requirements.
It has been postulated that scaffolds for bone regeneration
should have a minimum compressive strength of 2 MPa and
a minimum modulus of 50 MPa, which are at the low range
of properties for trabecular bone. Strength values reported
here for both scaffold designs are well within this suggested
value. Moduli for the low permeability scaffolds reached
50 MPa, whereas those of the high permeability design did
not. This is not particularly concerning though, since the
50 MPa modulus value refers to mature bone, and the scaf-
fold will primarily be supporting immature, developing
bone. The results suggest that the modulus of the high per-
meability scaffold/tissue construct will continue to increase
as more bone penetrates the void space and becomes min-
eralized. It would be prudent to also evaluate stiffer mate-
rials for their ability to regenerate bone successfully, but with
any material, a tradeoff exists between mechanical properties
and diffusion characteristics, as discussed below.
There is a balance that must be met between increasing mass
transport characteristics (in this case permeability) and pro-
viding adequate scaffold mechanical properties, both of which
are dependent on scaffold internal architecture and material.
For a given material, increasing permeability requires increas-
ing void space in the scaffold, thereby decreasing mechanical
properties. Expectedly, the two PCL scaffold designs (low and
high permeability) utilized in this work resulted in two dif-
ferent mechanical property profiles. Low permeability scaf-
folds had a significantly higher ( p£ 0.01) average modulus
than high permeability scaffolds. This trend endured through
the eighth week of in vivo implantation, suggesting that the
greater amount of PCL scaffold material in these scaffolds was
still supporting most of the mechanically applied load during
testing. For the high permeability design there was a significant
increase ( p£ 0.05) in mechanical properties at 8 weeks, which is
evident for both modulus and compressive yield strength. This
suggests that for this scaffold design, the bone in-growth and
penetration into the inside of the scaffold at 8 weeks is con-
tributing to the mechanical strength and beginning to bear
more load than the PCL scaffold itself. High permeability
scaffolds exhibited an increasing modulus trend from 4 to 8
weeks, which can be explained by the 117% increase in TMC
from 4 to 8 weeks for this design. This mature bone is capable of
bearing significant amounts of load during compressive testing
and appears to have a large influence on the mechanical
properties of the bone-PCL construct. This phenomenon was
not observed for the low permeability design, which may be
due to the lesser degree of bone in-growth and scaffold deg-
radation due to the presence of thicker struts. This suggests that
a high permeability scaffold design may be beneficial not only
for enhancing new bone growth as compared to less permeable
designs, but also for providing adequate mechanical properties
to support this developing tissue and surrounding tissues at
the implantation site.
Conclusions
In this study, scaffolds were created with rigorously con-
trolled architectures designed to specifically study the in-
fluence of permeability on bone regeneration. Results
presented here show that higher permeability scaffolds
support greater amounts of bone in-growth in a model that
utilizes BMP-7-transduced HGFs seeded into PCL scaffolds
and implanted in nude mice for up to 8 weeks. Bone in-
growth in high permeability scaffolds, in turn, increased the
mechanical properties of these PCL-bone constructs from 0 to
8 weeks. Future studies may include (1) longer time in vivo to
examine the effect of PCL degradation on construct fidelity
and to better understand the balance of tissue in-growth and
scaffold degradation over time, (2) expansion of permeability
ranges evaluated, and (3) testing of size-appropriate con-
structs in the orthotopic sites of large animals. From the
analyses presented here, we conclude that a more permeable
scaffold environment is more favorable for bone growth
using PCL scaffolds in our in vivo mouse model.
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